PARIS – Shiseido Europe said it has agreed to amass Gallinée Ltd., the microbiome skincare brand based in London.

Financial terms of the deal weren’t disclosed.

Skincare focused on the skin’s microbiome has been a rapidly growing category in the wonder industry, as wellness becomes a vital priority for consumers. The skin microbiome plays a key role in skin and overall health by protecting the body from the surface world.

“The acquisition of Gallinée exemplifies Shiseido’s commitment to the skin beauty category, helping us realize our mission to integrate skin beauty and inner beauty, as we proceed to position ourselves to ‘Be a Global Winner with Our Heritage,’” said Shiseido in a press release released Wednesday.

Shiseido Europe is a subsidiary of Shiseido Co. Ltd.

The Japanese beauty giant has within the recent past shed some holdings to deal with its core competency of skincare. In February 2021, the group revealed the sale of its personal care business in Japan to CVC Capital Partners in a deal valued at $1.5 billion. In April of that yr, it said it was concluding its licensing activities with Dolce & Gabbana. And that August, it sold Laura Mercier, Bare Minerals and Buxom to Advent International for $700 million.

Shiseido’s Win 2023 and Beyond strategy goals for the corporate to develop into the world’s largest skincare company by 2030.

Gallinée was founded by Marie Drago, a health care provider of pharmacy and a specialist in skin microbiome, in 2014. The brand’s product formulas include a patented complex of prebiotics, probiotics and postbiotics which can be said to nourish and strengthen skin’s microbiome.

Gallinée has 17 products spanning skincare, body care, hair care and supplements. They’re primarily sold within the U.K. and France today.

“Gallinée will deliver a complementary yet unique addition to Shiseido’s existing portfolio given its deal with beauty and wellness, in addition to its differentiated positioning throughout the emerging field of skin microbiome,” Shiseido said.

The group said the brand will have the option to leverage resources across its business infrastructure and research-and-development capabilities, particularly from Shiseido’s European Innovation Center.

Once the deal closes Drago is to affix Shiseido’s team within the Europe, Middle East and Africa region and proceed at Gallinée as its chief creative officer. She is going to report back to Franck Marilly, president and chief executive officer, Shiseido EMEA and global fragrance.